SUCCESS CASES
MULTIPLE METASTASIS
AIM
TUMORAL CONTROL AND QUALITY OF LIFE
66-year-old patient, diagnosed with lung cancer. Good initial response to chemotherapy but disease progression after exclusive treatment with immunotherapy. The patient is in good general condition and plays sports daily. In a routine check-up he was diagnosed in October 2022 with 6 small brain metastases. At his reference center they offer him palliative treatment through total brain irradiation.
Come to our center for a second opinion and we recommend, following international protocols, radiosurgery with radical intent for the 6 lesions, in a single session. We have administered an effective dose in 6 sessions with submillimeter precision, preserving the healthy brain in such a way that the average dose it receives is 30 times lower than a total brain treatment, which not only drastically reduces the toxic effects of radiation, but also which enables new treatments, in a harmless way, if necessary.
OPTICAL NERVE MENINGIOMA
AIM
TUMORAL CONTROL AND SAVE THE OPTICAL NUMBER
A 39-year-old woman who came to our center to evaluate radiosurgery for meningioma of the left optic nerve diagnosed as a result of discomfort in that eye. Since surgery is not possible, due to the risk of loss of vision, observation is maintained, showing progression of the lesion with protrusion of the eyeball out of the orbit.
She comes to our center and we propose radiosurgery in 5 sessions, with the aim of giving an effective dose to the tumor, preserving the function of the optic nerve.
PITUITARY MACROADENOMA
THE LARGEST TUMOR TREATED WITH ZAP X RADIOSURGERY
WE PRESERVE THE OPTICAL PATH
72-year-old patient diagnosed with Pituitary Adenoma in 2006, due to decreased visual acuity. He has been operated on 3 times with partial resections and progression after all interventions.
The patient consulted due to progression of visual deficit and a very voluminous tumor was observed that completely displaced the optic nerves. We propose a treatment using radiosurgery in 5 fractions, managing to administer a therapeutic dose to the tumor while protecting the optic pathway so as not to worsen the visual deficit.
SOLITAIRE FIBROUS TUMOR
AIM
TUMOR CONTROL AND LITTLE TOXICITY
66-year-old patient who debuted with facial paralysis in 2009, which is why he began a study. After suspicion of glomus jugulare tumor, he was referred to single-dose radiosurgery with a good initial response.
In 2018 he began again with symptoms of facial spasms, which is why he was diagnosed with progression. He receives a second single-dose radiosurgery treatment.
Subsequently, the facial paralysis progresses, so surgery is performed in September 2022, diagnosing a solitary fibrous tumor.
Because significant tumor residue persists, he consults to consider a third irradiation. Since the risk of causing injury to the carotid artery, which is attached to the tumor, is high, we decided to do radiosurgery treatment in 5 sessions with control of the dose in said artery.